Dipartimento di Chimica, Università degli Studi di Parma, Viale delle Scienze 17/A, 43123 Parma, Italy.
J Med Chem. 2012 Dec 13;55(23):10448-59. doi: 10.1021/jm301053a. Epub 2012 Dec 3.
This study reports the structure-activity relationship of a series of 8-hydroxoquinoline derivatives (8-HQs) and focuses on the cytotoxic activity of 5-Cl-7-I-8-HQ (clioquinol, CQ) copper complex (Cu(CQ)). 8-HQs alone cause a dose-dependent loss of viability of the human tumor HeLa and PC3 cells, but the coadministration of copper increases the ligands effects, with extensive cell death occurring in both cell lines. Cytotoxic doses of Cu(CQ) promote intracellular copper accumulation and massive endoplasmic reticulum vacuolization that precede a nonapoptotic (paraptotic) cell death. The cytotoxic effect of Cu(CQ) is reproduced in normal human endothelial cells (HUVEC) at concentrations double those effective in tumor cells, pointing to a potential therapeutic window for Cu(CQ). Finally, the results show that the paraptotic cell death induced by Cu(CQ) does not require nor involve caspases, giving an indication for the current clinical assessment of clioquinol as an antineoplastic agent.
本研究报告了一系列 8-羟基喹啉衍生物(8-HQs)的构效关系,并重点研究了 5-Cl-7-I-8-HQ(氯碘羟喹,CQ)铜配合物(Cu(CQ))的细胞毒性活性。8-HQs 本身可引起人肿瘤 HeLa 和 PC3 细胞的活力呈剂量依赖性丧失,但铜的共给药增加了配体的作用,两种细胞系均发生广泛的细胞死亡。细胞毒性剂量的 Cu(CQ) 可促进细胞内铜的积累和内质网大量空泡化,随后发生非凋亡(副凋亡)细胞死亡。在正常的人内皮细胞(HUVEC)中,Cu(CQ) 的细胞毒性作用在浓度上与在肿瘤细胞中有效浓度相同的情况下得到重现,这表明 Cu(CQ) 具有潜在的治疗窗。最后,结果表明,Cu(CQ) 诱导的副凋亡细胞死亡不需要也不涉及半胱天冬酶,这为当前临床评估氯碘羟喹作为抗肿瘤药物提供了依据。